1 Market Overview
    1.1 Product Overview and Scope of Biopharmaceutical and Bio-CDMO
    1.2 Global Biopharmaceutical and Bio-CDMO Market Size and Forecast
    1.3 China Biopharmaceutical and Bio-CDMO Market Size and Forecast
    1.4 China Percentage in Global Market
        1.4.1 By Revenue, China Biopharmaceutical and Bio-CDMO Share in Global Market, 2020-2031
        1.4.2 Biopharmaceutical and Bio-CDMO Market Size: China VS Global, 2020-2031
    1.5 Biopharmaceutical and Bio-CDMO Market Dynamics
        1.5.1 Biopharmaceutical and Bio-CDMO Market Drivers
        1.5.2 Biopharmaceutical and Bio-CDMO Market Restraints
        1.5.3 Biopharmaceutical and Bio-CDMO Industry Trends
        1.5.4 Biopharmaceutical and Bio-CDMO Industry Policy
2 Competitive Landscape by Company
    2.1 Global Biopharmaceutical and Bio-CDMO Revenue by Company, 2020-2025
    2.2 Global Biopharmaceutical and Bio-CDMO Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.3 Global Biopharmaceutical and Bio-CDMO Concentration Ratio
    2.4 Global Biopharmaceutical and Bio-CDMO Mergers & Acquisitions, Expansion Plans
    2.5 Global Biopharmaceutical and Bio-CDMO Manufacturers Product Type
    2.6 Global Geographic Distribution of Biopharmaceutical and Bio-CDMO Companies
3 China Competitive Situation by Company
    3.1 China Biopharmaceutical and Bio-CDMO Revenue by Company, 2020-2025
    3.2 China Biopharmaceutical and Bio-CDMO Biopharmaceutical and Bio-CDMO Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    3.3 China Biopharmaceutical and Bio-CDMO Market, Revenue Percentage of Local Players VS Foreign Players (2020-2031)
4 Industry Chain Analysis
    4.1 Biopharmaceutical and Bio-CDMO Industry Chain
    4.2 Biopharmaceutical and Bio-CDMO Upstream Analysis
    4.3 Biopharmaceutical and Bio-CDMO Midstream Analysis
    4.4 Biopharmaceutical and Bio-CDMO Downstream Analysis
5 Sights by Type
    5.1 Biopharmaceutical and Bio-CDMO Classification
        5.1.1 Cell and Gene Therapies
        5.1.2 Antibodies
        5.1.3 Vaccines
        5.1.4 Other
    5.2 by Type, Global Biopharmaceutical and Bio-CDMO Market Size & CAGR, 2020 VS 2024 VS 2031
    5.3 by Type, Global Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
6 Sights by Application
    6.1 Biopharmaceutical and Bio-CDMO Segment by Application
        6.1.1 SMBs
        6.1.2 Large Companies
    6.2 by Application, Global Biopharmaceutical and Bio-CDMO Market Size & CAGR, 2020 VS 2024 VS 2031
    6.3 by Application, Global Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
7 Sights by Region
    7.1 By Region, Global Biopharmaceutical and Bio-CDMO Market Size, 2020 VS 2024 VS 2031
    7.2 By Region, Global Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
    7.3 North America
        7.3.1 North America Biopharmaceutical and Bio-CDMO Market Size & Forecasts, 2020-2031
        7.3.2 By Country, North America Biopharmaceutical and Bio-CDMO Market Size Market Share
    7.4 Europe
        7.4.1 Europe Biopharmaceutical and Bio-CDMO Market Size & Forecasts, 2020-2031
        7.4.2 By Country, Europe Biopharmaceutical and Bio-CDMO Market Size Market Share
    7.5 Asia Pacific
        7.5.1 Asia Pacific Biopharmaceutical and Bio-CDMO Market Size & Forecasts, 2020-2031
        7.5.2 By Country/Region, Asia Pacific Biopharmaceutical and Bio-CDMO Market Size Market Share
    7.6 South America
        7.6.1 South America Biopharmaceutical and Bio-CDMO Market Size & Forecasts, 2020-2031
        7.6.2 By Country, South America Biopharmaceutical and Bio-CDMO Market Size Market Share
    7.7 Middle East & Africa
8 Sights by Country Level
    8.1 By Country, Global Biopharmaceutical and Bio-CDMO Market Size & CAGR，2020 VS 2024 VS 2031
    8.2 By Country, Global Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
    8.3 United States
        8.3.1 United States Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.3.2 By Company, United States Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.3.3 by Type, United States Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.3.4 by Application, United States Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
    8.4 Europe
        8.4.1 Europe Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.4.2 By Company, Europe Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.4.3 by Type, Europe Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.4.4 by Application, Europe Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
    8.5 China
        8.5.1 China Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.5.2 By Company, China Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.5.3 by Type, China Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.5.4 by Application, China Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
    8.6 Japan
        8.6.1 Japan Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.6.2 By Company, Japan Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.6.3 by Type, Japan Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.6.4 by Application, Japan Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
    8.7 South Korea
        8.7.1 South Korea Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.7.2 By Company, South Korea Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.7.3 by Type, South Korea Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.7.4 by Application, South Korea Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
    8.8 Southeast Asia
        8.8.1 Southeast Asia Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.8.2 By Company, Southeast Asia Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.8.3 by Type, Southeast Asia Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.8.4 by Application, Southeast Asia Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
    8.9 India
        8.9.1 India Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.9.2 By Company, India Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.9.3 by Type, India Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.9.4 by Application, India Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
    8.10 Middle East & Africa
        8.10.1 Middle East & Africa Biopharmaceutical and Bio-CDMO Market Size, 2020-2031
        8.10.2 By Company, Middle East & Africa Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024
        8.10.3 by Type, Middle East & Africa Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
        8.10.4 by Application, Middle East & Africa Biopharmaceutical and Bio-CDMO Revenue Market Share, 2024 VS 2031
9 Company Profile
    9.1 Lonza
        9.1.1 Lonza Company Information, Head Office, Market Area, and Industry Position
        9.1.2 Lonza Company Profile and Main Business
        9.1.3 Lonza Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.1.4 Lonza Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.1.5 Lonza Recent Developments
    9.2 Catalent
        9.2.1 Catalent Company Information, Head Office, Market Area, and Industry Position
        9.2.2 Catalent Company Profile and Main Business
        9.2.3 Catalent Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.2.4 Catalent Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.2.5 Catalent Recent Developments
    9.3 Samsung Biologics
        9.3.1 Samsung Biologics Company Information, Head Office, Market Area, and Industry Position
        9.3.2 Samsung Biologics Company Profile and Main Business
        9.3.3 Samsung Biologics Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.3.4 Samsung Biologics Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.3.5 Samsung Biologics Recent Developments
    9.4 FUJIFILM Diosynth Biotechnologies
        9.4.1 FUJIFILM Diosynth Biotechnologies Company Information, Head Office, Market Area, and Industry Position
        9.4.2 FUJIFILM Diosynth Biotechnologies Company Profile and Main Business
        9.4.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.4.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.4.5 FUJIFILM Diosynth Biotechnologies Recent Developments
    9.5 Boehringer Ingelheim
        9.5.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
        9.5.2 Boehringer Ingelheim Company Profile and Main Business
        9.5.3 Boehringer Ingelheim Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.5.4 Boehringer Ingelheim Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.5.5 Boehringer Ingelheim Recent Developments
    9.6 WuXi Biologics
        9.6.1 WuXi Biologics Company Information, Head Office, Market Area, and Industry Position
        9.6.2 WuXi Biologics Company Profile and Main Business
        9.6.3 WuXi Biologics Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.6.4 WuXi Biologics Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.6.5 WuXi Biologics Recent Developments
    9.7 Recipharm
        9.7.1 Recipharm Company Information, Head Office, Market Area, and Industry Position
        9.7.2 Recipharm Company Profile and Main Business
        9.7.3 Recipharm Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.7.4 Recipharm Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.7.5 Recipharm Recent Developments
    9.8 Thermo Fisher Scientific
        9.8.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
        9.8.2 Thermo Fisher Scientific Company Profile and Main Business
        9.8.3 Thermo Fisher Scientific Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.8.4 Thermo Fisher Scientific Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.8.5 Thermo Fisher Scientific Recent Developments
    9.9 AGC Biologics
        9.9.1 AGC Biologics Company Information, Head Office, Market Area, and Industry Position
        9.9.2 AGC Biologics Company Profile and Main Business
        9.9.3 AGC Biologics Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.9.4 AGC Biologics Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.9.5 AGC Biologics Recent Developments
    9.10 Rentschler Biopharma
        9.10.1 Rentschler Biopharma Company Information, Head Office, Market Area, and Industry Position
        9.10.2 Rentschler Biopharma Company Profile and Main Business
        9.10.3 Rentschler Biopharma Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.10.4 Rentschler Biopharma Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.10.5 Rentschler Biopharma Recent Developments
    9.11 KBI Biopharma
        9.11.1 KBI Biopharma Company Information, Head Office, Market Area, and Industry Position
        9.11.2 KBI Biopharma Company Profile and Main Business
        9.11.3 KBI Biopharma Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.11.4 KBI Biopharma Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.11.5 KBI Biopharma Recent Developments
    9.12 Siegfried
        9.12.1 Siegfried Company Information, Head Office, Market Area, and Industry Position
        9.12.2 Siegfried Company Profile and Main Business
        9.12.3 Siegfried Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.12.4 Siegfried Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.12.5 Siegfried Recent Developments
    9.13 Aenova Group
        9.13.1 Aenova Group Company Information, Head Office, Market Area, and Industry Position
        9.13.2 Aenova Group Company Profile and Main Business
        9.13.3 Aenova Group Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.13.4 Aenova Group Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.13.5 Aenova Group Recent Developments
    9.14 GenScript
        9.14.1 GenScript Company Information, Head Office, Market Area, and Industry Position
        9.14.2 GenScript Company Profile and Main Business
        9.14.3 GenScript Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.14.4 GenScript Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.14.5 GenScript Recent Developments
    9.15 ProBioGen
        9.15.1 ProBioGen Company Information, Head Office, Market Area, and Industry Position
        9.15.2 ProBioGen Company Profile and Main Business
        9.15.3 ProBioGen Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.15.4 ProBioGen Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.15.5 ProBioGen Recent Developments
    9.16 Northway Biotech
        9.16.1 Northway Biotech Company Information, Head Office, Market Area, and Industry Position
        9.16.2 Northway Biotech Company Profile and Main Business
        9.16.3 Northway Biotech Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.16.4 Northway Biotech Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.16.5 Northway Biotech Recent Developments
    9.17 3P Biopharmaceuticals
        9.17.1 3P Biopharmaceuticals Company Information, Head Office, Market Area, and Industry Position
        9.17.2 3P Biopharmaceuticals Company Profile and Main Business
        9.17.3 3P Biopharmaceuticals Biopharmaceutical and Bio-CDMO Models, Specifications, and Application
        9.17.4 3P Biopharmaceuticals Biopharmaceutical and Bio-CDMO Revenue and Gross Margin, 2020-2025
        9.17.5 3P Biopharmaceuticals Recent Developments
10 Conclusion
11 Appendix
    11.1 Research Methodology
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Market Estimation Model
    11.4 Disclaimer